0001209191-23-027196.txt : 20230503 0001209191-23-027196.hdr.sgml : 20230503 20230503205354 ACCESSION NUMBER: 0001209191-23-027196 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230320 FILED AS OF DATE: 20230503 DATE AS OF CHANGE: 20230503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Valence Investments SPV IV LLC CENTRAL INDEX KEY: 0001812080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39538 FILM NUMBER: 23886054 BUSINESS ADDRESS: STREET 1: 590 MADISON AVENUE 21ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-521-4379 MAIL ADDRESS: STREET 1: 590 MADISON AVENUE 21ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Valence Investments SPV VI, LLC CENTRAL INDEX KEY: 0001971787 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39538 FILM NUMBER: 23886052 BUSINESS ADDRESS: STREET 1: 590 MADISON AVENUE 21ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-521-4379 MAIL ADDRESS: STREET 1: 590 MADISON AVENUE 21ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Valence Investments SPV V, LLC CENTRAL INDEX KEY: 0001854361 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39538 FILM NUMBER: 23886053 BUSINESS ADDRESS: STREET 1: 590 MADISON AVENUE 21ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-521-4379 MAIL ADDRESS: STREET 1: 590 MADISON AVENUE 21ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CalciMedica, Inc. CENTRAL INDEX KEY: 0001534133 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452120079 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 COAST BOULEVARD SOUTH STREET 2: SUITE 307 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-952-5500 MAIL ADDRESS: STREET 1: 505 COAST BOULEVARD SOUTH STREET 2: SUITE 307 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: CalciMedica, Inc. /DE/ DATE OF NAME CHANGE: 20230322 FORMER COMPANY: FORMER CONFORMED NAME: GRAYBUG VISION, INC. DATE OF NAME CHANGE: 20170717 FORMER COMPANY: FORMER CONFORMED NAME: GRAYBUG, Inc. DATE OF NAME CHANGE: 20150303 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-03-20 0 0001534133 CalciMedica, Inc. CALC 0001812080 Valence Investments SPV IV LLC 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022 0 0 1 0 0001854361 Valence Investments SPV V, LLC 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022 0 0 1 0 0001971787 Valence Investments SPV VI, LLC 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022 0 0 1 0 0 Common Stock 2023-03-20 4 A 0 356989 A 356989 D Common Stock 2023-03-20 4 A 0 66228 A 66228 I By Valence Investments SPV V, LLC Common Stock 2023-03-20 4 A 0 316109 A 316109 I By Valence Investments SPV VI, LLC Warrant 27.94 2023-03-20 4 A 0 9935 A 2026-02-22 Common Stock 9935 9935 I By Valence Investments SPV V, LLC Warrant 27.94 2023-03-20 4 A 0 9935 A 2026-06-25 Common Stock 9935 9935 I By Valence Investments SPV V, LLC Received in exchange for an aggregate of 12,395,423 shares of common stock of CalciMedica, Inc. ("CalciMedica") pursuant to an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among CalciMedica, the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"). Under the terms of the Merger Agreement, on March 20, 2023, Merger Sub merged with and into CalciMedica (the "Merger"), with CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. Received in exchange for 2,299,564 shares of the common stock of CalciMedica pursuant to the Merger Agreement. Received in exchange for 10,975,977 shares of the common stock of CalciMedica pursuant to the Merger Agreement. Immediately exercisable. Received in exchange for a warrant to acquire 344,934 shares of common stock of CalciMedica pursuant to the Merger Agreement. Valence Investments SPV IV, LLC, by /s/ Eric Roberts, Manager 2023-05-03 Valence Investments SPV V, LLC, by /s/ Eric Roberts, Manager 2023-05-03 Valence Investments SPV VI, LLC, by /s/ Eric Roberts, Manager 2023-05-03